CFP
ABBV icon

Curran Financial Partners’s AbbVie ABBV Stock Holding History

Curran Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$445K Buy
2,048
+183
+10% +$40.6K 0.08% 87
2025
Q4 		$426K Hold
1,865
– – 0.08% 87
2025
Q3 		$432K Sell
1,865
-350
-16% -$71.3K 0.09% 96
2025
Q2 		$411K Sell
2,215
-159
-7% -$29.6K 0.09% 89
2025
Q1 		$497K Buy
2,374
+1
+0% +$194 0.12% 65
2024
Q4 		$422K Buy
2,373
+439
+23% +$80.7K 0.11% 67
2024
Q3 		$382K Buy
1,934
+8
+0.4% +$1.49K 0.11% 68
2024
Q2 		$330K Buy
1,926
+89
+5% +$14.7K 0.11% 66
2024
Q1 		$335K Sell
1,837
-69
-4% -$11.9K 0.12% 66
2023
Q4 		$313K Sell
1,906
-10
-0.5% -$1.46K 0.12% 63
2023
Q3 		$286K Buy
1,916
+48
+3% +$7.05K 0.12% 58
2023
Q2 		$252K Sell
1,868
-19
-1% -$2.79K 0.11% 64
2023
Q1 		$301K Buy
1,887
+8
+0.4% +$1.22K 0.14% 55
2022
Q4 		$304K Sell
1,879
-213
-10% -$32.7K 0.15% 57
2022
Q3 		$281K Sell
2,092
-7
-0.3% -$1K 0.14% 52
2022
Q2 		$321K Buy
2,099
+24
+1% +$3.67K 0.15% 49
2022
Q1 		$336K Sell
2,075
-219
-10% -$31.8K 0.14% 61
2021
Q4 		$311K Buy
+2,294
New +$271K 0.13% 58

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Curran Financial Partners's ABBV Position: Q1 2026 in Review

Curran Financial Partners increased its AbbVie (ABBV) stake by 9.8% in Q1 2026, buying an estimated $40.6K and bringing the position to 2,048 shares worth $445K. The position accounts for 0.08% of the portfolio, ranked #87.

Curran Financial Partners first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $497K in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Curran Financial Partners held 2,048 shares of AbbVie worth $445K as of Q1 2026.
  • Curran Financial Partners bought 183 AbbVie shares in Q1 2026, an estimated $40.6K.
  • AbbVie made up 0.08% of Curran Financial Partners's portfolio in Q1 2026, its #87 holding.
  • Curran Financial Partners first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Curran Financial Partners's AbbVie position peaked at $497K in Q1 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Curran Financial Partners's 13F filing for Q1 2026, filed 15 Apr 2026.